title: A doxycycline-inducible, tissue-specific aromatase-expressing transgenic mouse.
abstract: Aromatase converts androgens to estrogens and it is expressed in gonads and non-reproductive tissues (e.g. brain and adipose tissues). As circulating levels of estrogens in males are low, we hypothesize that local estrogen production is important for the regulation of physiological functions (e.g. metabolism) and pathological development (e.g. breast and prostate cancers) by acting in a paracrine and/or intracrine manner. We generated a tissue-specific doxycycline-inducible, aromatase transgenic mouse to test this hypothesis. The transgene construct (pTetOAROM) consists of a full-length human aromatase cDNA (hAROM) and a luciferase gene under the control of a bi-directional tetracycline-responsive promoter (pTetO), which is regulated by transactivators (rtTA or tTA) and doxycycline. Our in vitro studies using MBA-MB-231tet cells stably expressing rtTA, showed that doxycycline treatment induced transgene expression of hAROM transcripts by 17-fold (P = 0.01), aromatase activity by 26-fold, (P = 0.0008) and luciferase activity by 9.6-fold (P = 0.0006). Pronuclear microinjection of the transgene generated four pTetOAROM founder mice. A male founder was bred with a female mammary gland-specific rtTA mouse (MMTVrtTA) to produce MMTVrtTA-pTetOAROM double-transgenic mice. Upon doxycycline treatment via drinking water, human aromatase expression was detected by RT-PCR, specifically in mammary glands, salivary glands and seminal vesicles of double-stransgenic mice. Luciferase expression and activity was detected in these tissues by in vivo bioluminescence imaging, in vitro luciferase assay and RT-PCR. In summary, we generated a transgenic mouse model that expresses the human aromatase transgene in a temporal- and spatial-specific manner, which will be a useful model to study the physiological importance of local estrogen production.
authors: Prince Henry's Institute, Clayton, VIC, 3168, Australia.
authors: Jenny D Y
authors: JD
authors: Chow
authors: John T
authors: JT
authors: Price
authors: Margaret M
authors: MM
authors: Bills
authors: Evan R
authors: ER
authors: Simpson
authors: Wah Chin
authors: WC
authors: Boon
references: Mol Cell Biol. 1990 Nov;10(11):5822-9
references: 1700274
references: Reprod Sci. 2008 Dec;15(10):1044-53
references: 18955734
references: J Neuroendocrinol. 2009 Mar;21(4):365-9
references: 19226348
references: J Clin Endocrinol Metab. 2004 Jan;89(1):61-70
references: 14715828
references: J Bone Miner Res. 2009 Jul;24(7):1263-70
references: 19257817
references: J Steroid Biochem Mol Biol. 2005 May;95(1-5):49-55
references: 15955692
references: J Clin Endocrinol Metab. 2002 Jun;87(6):2849-56
references: 12050262
references: J Immunol. 2003 Jun 15;170(12):6307-19
references: 12794164
references: J Clin Endocrinol Metab. 1981 Aug;53(2):412-7
references: 7251819
references: Curr Opin Mol Ther. 1999 Oct;1(5):565-72
references: 11249663
references: J Steroid Biochem Mol Biol. 2003 Sep;86(3-5):225-30
references: 14623515
references: J Steroid Biochem Mol Biol. 2001 Dec;79(1-5):193-201
references: 11850225
references: J Steroid Biochem Mol Biol. 2009 Jul;115(3-5):115-25
references: 19500729
references: Cancer Res. 1996 Jul 15;56(14):3180-5
references: 8764102
references: Arzneimittelforschung. 1981;31(12):2116-7
references: 7199309
references: Curr Opin Biotechnol. 1992 Oct;3(5):506-11
references: 1368935
references: J Endocrinol. 1976 Oct;71(1):77-85
references: 978120
references: FASEB J. 2002 Mar;16(3):283-92
references: 11874978
references: J Biol Chem. 1993 Sep 15;268(26):19463-70
references: 7690033
references: N Engl J Med. 1997 Jul 10;337(2):91-5
references: 9211678
references: Hum Pathol. 1994 May;25(5):530-5
references: 8200649
references: Transgenic Res. 2002 Aug;11(4):361-72
references: 12212839
references: J Steroid Biochem Mol Biol. 2003 Sep;86(3-5):219-24
references: 14623514
references: Clin Endocrinol (Oxf). 2007 Aug;67(2):218-24
references: 17547681
references: J Biomol Tech. 2007 Apr;18(2):120-3
references: 17496224
references: Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11312-6
references: 8248245
references: Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4575-80
references: 10200304
references: Biochem Pharmacol. 1991 Feb 15;41(4):638-41
references: 1997011
references: Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5547-51
references: 1319065
references: Cancer Lett. 2009 Jan 8;273(1):15-27
references: 18614276
references: Endocrinology. 2000 Jun;141(6):2050-3
references: 10830289
references: J Clin Endocrinol Metab. 1995 Dec;80(12):3689-98
references: 8530621
references: FASEB J. 2000 May;14(7):877-84
references: 10783141
references: Genesis. 2009 Apr;47(4):274-80
references: 19241392
references: Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):7986-91
references: 10393934
references: Mol Cell Endocrinol. 1987 Aug;52(3):267-72
references: 3653507
references: Arzneimittelforschung. 1984;34(4):446-8
references: 6540103
references: Methods Enzymol. 1991;206:477-83
references: 1784232
references: Brain Res Mol Brain Res. 2005 Oct 31;140(1-2):127-32
references: 16083992
references: Cancer Res. 2005 Jan 15;65(2):657-63
references: 15695411
references: Endocrinology. 2001 Jun;142(6):2435-42
references: 11356692